Bayer Raises 2026 Profit Outlook on Strong Pharma Sales
Bayer has raised its profit outlook for 2026 following stronger-than-expected third-quarter sales from its pharmaceuticals division. The German company also lowered its debt forecast, indicating improved growth momentum and a stronger financial position going forward.
ET Markets·


